Page last updated: 2024-10-30

labetalol and Central Hypothyroidism

labetalol has been researched along with Central Hypothyroidism in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
" It was a prerequisite to establish the bioavailability of oxazepam prior to succeeding studies on the oral disposition of the drug."2.38Factors and conditions affecting the glucuronidation of oxazepam. ( Sonne, J, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonne, J1

Reviews

1 review available for labetalol and Central Hypothyroidism

ArticleYear
Factors and conditions affecting the glucuronidation of oxazepam.
    Pharmacology & toxicology, 1993, Volume: 73 Suppl 1

    Topics: Acetaminophen; Age Factors; Aged; Aged, 80 and over; Biological Availability; Biotransformation; Die

1993